Soc. Generale Knock-Out CEC/ DE000SW5UHB1 /
2024-05-23 4:40:11 PM | Chg.0.000 | Bid5:39:30 PM | Ask5:39:30 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.930EUR | 0.00% | 0.930 Bid Size: 7,000 |
0.960 Ask Size: 7,000 |
CECONOMY AG INH O.N... | 2.0599 EUR | 2078-12-31 | Call |
GlobeNewswire
5:51 PM
Akero Therapeutics, Inc. (AKRO) Investors: June 25, 2024 Filing Deadline in Securities Class Action ...
GlobeNewswire
5:50 PM
Contact Hagens Berman by June 28, 2024 Deadline to Join Class Action Against Malibu Boats (MBUU)
GlobeNewswire
5:46 PM
Luna Innovations (LUNA) Faces Extended Class Period After Admitting to Improper Revenue Recognition ...
GlobeNewswire
5:41 PM
Tyson Group Named to Selling Power Magazine’s Top Sales Training Companies 2024 List
GlobeNewswire
5:30 PM
Northrop Grumman to Participate in Bernstein’s 40th Annual Strategic Decisions Conference
GlobeNewswire
5:07 PM
Benevis Delivers Free Dental Care to 413 Children and Adults in Need During Ninth Annual Sharing Smi...
GlobeNewswire
5:06 PM
Vive Crop Protection Secures Series C Extension Funding to Accelerate Agricultural Innovation
GlobeNewswire
5:05 PM
Rackspace Technology Further Establishes Market Leadership by Being Named Dell Technologies Global A...
GlobeNewswire
5:05 PM
Kno2 and Docusign Revolutionize Provider-to-Provider Signature Workflows in Healthcare
GlobeNewswire
5:00 PM
New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing ...
GlobeNewswire
5:00 PM
FC Barcelona Selects Fortinet as its Official Cybersecurity Partner for the Future Spotify Camp Nou
GlobeNewswire
5:00 PM
John Swett Unified School District Collaborates with ENGIE to Achieve Energy Sustainability and Supp...
GlobeNewswire
5:00 PM
A VERY GOOD BOY? Combines Faith, Crime, and Suspense in a Harrowing Teen Drama
GlobeNewswire
5:00 PM
Teacher Decolonizes Science And Creates A Well of Opportunity and Learning For Ft. Hall Indian Reser...
GlobeNewswire
4:51 PM
BPMC INVESTOR ALERT: Andrews & Springer LLC Investigates Blueprint Medicines Corporation